Related Experiment Video
Updated: Jun 29, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Cranial involvement in giant cell arteritis
Philipp Bosch1, Georgina Espigol-Frigolé2, Maria C Cid2
1Department of Rheumatology and Immunology, Medical University of Graz, Graz, Austria.
Insights
Giant cell arteritis research has improved diagnosis and management. Current studies focus on large vessel involvement, new therapies to reduce steroid use, and updated clinical guidelines.
Area of Science:
- Rheumatology
- Vascular Medicine
- Internal Medicine
Background:
- Giant cell arteritis (GCA) is a vasculitis affecting large arteries, primarily the aorta and its branches.
- Historically diagnosed based on cranial artery involvement, GCA is now recognized to frequently impact extracranial large vessels.
- Advances in understanding GCA pathophysiology have spurred the development of novel therapeutic strategies.
Purpose of the Study:
- To review the current understanding of giant cell arteritis, focusing on cranial manifestations.
- To outline the contemporary clinical approach to diagnosing and managing GCA.
- To explore emerging research and future directions in GCA patient care.
Main Methods:
- Literature review of recent advancements in GCA research.
- Analysis of updated classification criteria and management recommendations.
- Synthesis of basic, translational, and clinical research findings.
Main Results:
- Significant progress in GCA diagnosis and patient management since 1890.
- Recognition of widespread large vessel involvement in GCA beyond cranial arteries.
- Development of new therapeutic agents aiming to minimize glucocorticoid dependence and prevent disease flares.
Conclusions:
- GCA is a complex vasculitis with significant large vessel implications.
- Updated guidelines and novel therapies are transforming GCA management.
- Ongoing research promises further improvements in GCA treatment and patient outcomes.
Abstract:
Since its first clinical description in 1890, extensive research has advanced our understanding of giant cell arteritis, leading to improvements in both diagnosis and management for affected patients. Imaging studies have shown that the disease frequently extends beyond the typical cranial arteries, also affecting large vessels such as the aorta and its proximal branches. Meanwhile, advances in comprehending the underlying pathophysiology of giant cell arteritis have given rise to numerous potential therapeutic agents, which aim to minimise the need for glucocorticoid treatment and prevent flares. Classification criteria for giant cell arteritis, as well as recommendations for management, imaging, and treat-to-target have been developed or updated in the last 5 years, and current research encompasses a broad spectrum covering basic, translational, and clinical research. In this Series paper, we aim to discuss the current understanding of giant cell arteritis with cranial manifestations, describe the clinical approach to this condition, and explore future directions in research and patient care.
More Related Videos
07:28Visualizing the Calcitonin Gene-Related Peptide Immunoreactive Innervation of the Rat Cranial Dura Mater with Immunofluorescence and Neural Tracing
Published on: January 6, 2021
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
The Arch of Aorta
Encircling the heart, the coronary arteries form a ring-like structure before...